Corticosteroid formulation comprising less than 2.5 mg...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/573 (2006.01) A61P 9/02 (2006.01)

Patent

CA 2422991

A unit dose formulation comprises less than 2.5 mg of prednisolone or an equivalent, equipotent amount of another corticosteroid. Once daily administration of the unit dose formulation between midnight and 6 a.m. for the treatment of rheumatoid arthritis.

Formulation d'une dose unitaire comprenant moins de 2,5 mg de prednisolone ou une quantité équivalente et équipotente d'un autre corticostéroïde. L'administration quotidienne en une seule fois de la formulation de la dose unitaire se fait entre minuit et 6 heures du matin pour le traitement de l'arthrite rhumatoïde.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Corticosteroid formulation comprising less than 2.5 mg... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Corticosteroid formulation comprising less than 2.5 mg..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Corticosteroid formulation comprising less than 2.5 mg... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1705684

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.